[Pharmacological basis of the symptomatic treatment of arterial hypertension. II. Antihypertensive agent combinations].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004336:Drug Antagonism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D005730:Ganglionic Blockers; D006571:Heterocyclic Compounds; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D008750:Methyldopa; D012110:Reserpine; D003000:Clonidine; D003981:Diazoxide; D006145:Guanethidine
Bases pharmacologiques du traitement symptomatique de l'hypertension artérielle. II. Les associations d'antihypertenseurs entre eux